Edition:
United States

Veru Inc (VERU.OQ)

VERU.OQ on NASDAQ Stock Exchange Capital Market

1.24USD
15 Dec 2017
Change (% chg)

$0.02 (+1.64%)
Prev Close
$1.22
Open
$1.21
Day's High
$1.30
Day's Low
$1.15
Volume
32,111
Avg. Vol
28,882
52-wk High
$2.99
52-wk Low
$0.90

Select another date:

Mon, Dec 11 2017

BRIEF-Veru Acquires Novel Proprietary Formulation For Overactive Bladder

* VERU ACQUIRES NOVEL PROPRIETARY FORMULATION FOR OVERACTIVE BLADDER

BRIEF-Veru announces Tamsulosin drs bioequivalence clinical trial results

* Veru announces Tamsulosin Drs bioequivalence clinical trial results

BRIEF-Veru files for mixed shelf of up to $50 million

* Files for mixed shelf of up to $50 million - SEC filing‍​ Source text: (http://bit.ly/2lfqJfT) Further company coverage:

BRIEF-Veru announces agreement with Timm Medical Technologies to distribute and to promote preboost

* Veru Inc announces agreement with Timm Medical Technologies LLC to distribute and to promote preboost

BRIEF-Veru Inc initiates telemedicine capability to expand access to prescriptions for FC2 female condom

* Veru Inc announces initiation of telemedicine capability to expand access to prescriptions for FC2 female condom Source text for Eikon: Further company coverage:

BRIEF-Ajwan Gulf Real Estate to acquire stake in Health Co and Emaar Food Group

* BOARD APPROVES TO COMPLETE ACQUISITION OF HEALTH CO, ACQUISITION OF 70 PERCENT STAKE IN EMAAR FOOD GROUP

BRIEF-Veru reports Q3 loss per share $0.03

* Qtrly unit sales totaled 8.5 million, which is 21 percent lower than 10.7 million from same prior-year quarter

Select another date: